Dong-A ST Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	3.7yrs

Recente managementupdates

Recent updates

Is Dong-A ST (KRX:170900) A Risky Investment?

Oct 16

Investor Optimism Abounds Dong-A ST Co., Ltd. (KRX:170900) But Growth Is Lacking

Aug 21

Dong-A ST's (KRX:170900) Shareholders Have More To Worry About Than Only Soft Earnings

Mar 25

Dong-A ST Co., Ltd. (KRX:170900) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Mar 07

Is Dong-A ST Co., Ltd.'s (KRX:170900) Stock's Recent Performance A Reflection Of Its Financial Health?

Feb 09

Is Dong-A ST Co., Ltd. (KRX:170900) Popular Amongst Institutions?

Jan 25

Is Dong-A ST Co., Ltd. (KRX:170900) A Good Fit For Your Dividend Portfolio?

Jan 11

Be Sure To Check Out Dong-A ST Co., Ltd. (KRX:170900) Before It Goes Ex-Dividend

Dec 25

Dong-A ST (KRX:170900) Has A Rock Solid Balance Sheet

Dec 22

Calculating The Intrinsic Value Of Dong-A ST Co., Ltd. (KRX:170900)

Dec 07

A Look At Dong-A ST's (KRX:170900) Share Price Returns

Nov 19

CEO

Dong-A ST heeft geen CEO, of we hebben geen gegevens over hen.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Sung-Keun Lee	CFO & Executive Director	4.7yrs	geen gegevens	geen gegevens
Hak-Jun Kim	Independent Outside Director	4.7yrs	geen gegevens	geen gegevens
Bum-Joon Kim	Independent Outside Director	2.7yrs	geen gegevens	geen gegevens
Jae-Hong Park	Inside Director	2.7yrs	geen gegevens	geen gegevens

3.7yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van A170900 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).

Dong-A ST Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Less than half of directors are independent

Dong-A ST Co., Ltd., Annual General Meeting, Mar 26, 2024

Dong-A ST Co., Ltd., Annual General Meeting, Mar 26, 2024

High number of new directors

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Dong-A ST Co., Ltd. to Report Q3, 2024 Results on Nov 01, 2024

Is Dong-A ST (KRX:170900) A Risky Investment?

US FDA Approves Dong-A ST's Imuldosa (ustekinumab-Sslf), a Biosimilar to Stelara

New minor risk - Shareholder dilution

Investor Optimism Abounds Dong-A ST Co., Ltd. (KRX:170900) But Growth Is Lacking

Dong-A ST Co., Ltd. to Report First Half, 2024 Results on Jul 25, 2024

Price target increased by 8.5% to ₩84,247

Less than half of directors are independent

Dong-A ST Co., Ltd. to Report Q1, 2024 Results on May 02, 2024

Dong-A ST's (KRX:170900) Shareholders Have More To Worry About Than Only Soft Earnings

Full year 2023 earnings released: EPS: ₩1,311 (vs ₩1,606 in FY 2022)

Dong-A ST Co., Ltd. (KRX:170900) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Dong-A ST Co., Ltd., Annual General Meeting, Mar 26, 2024

Dong-A ST Co., Ltd., Annual General Meeting, Mar 26, 2024

Price target increased by 7.6% to ₩77,624

Now 22% overvalued after recent price rise

Dong-A ST Co., Ltd. to Report Fiscal Year 2023 Results on Feb 15, 2024

FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara

Upcoming dividend of ₩686 per share at 1.1% yield

New minor risk - Profit margin trend

Investor sentiment improves as stock rises 21%

New minor risk - Share price stability

Investor sentiment improves as stock rises 28%

Dong-A ST Co., Ltd. to Report Q2, 2023 Results on Jul 27, 2023

Now 21% undervalued after recent price drop

EMA Accepts MAA for DMB-3115 of Dong-A ST, a Stelara Biosimilar

Full year 2022 earnings released: EPS: ₩1,606 (vs ₩1,519 in FY 2021)

Dong-A ST Co., Ltd. Demonstrates Therapeutic Equivalence Between DMB-3115 and Stelara in Global Phase III

Upcoming dividend of ₩1,000 per share

High number of new directors

Price target decreased to ₩77,200

Price target decreased to ₩95,667

Less than half of directors are independent

Less than half of directors are independent

Upcoming dividend of ₩1,000 per share

Price target decreased to ₩105,000

Does Dong-A ST (KRX:170900) Have A Healthy Balance Sheet?

Dong-A ST's (KRX:170900) Problems Go Beyond Weak Profit

Full year 2020 earnings released: EPS ₩3,212 (vs ₩8,404 in FY 2019)

A Look At The Fair Value Of Dong-A ST Co., Ltd. (KRX:170900)

Dong-A ST Co., Ltd., Annual General Meeting, Mar 24, 2021

New 90-day low: ₩82,100

A Look At Dong-A ST's (KRX:170900) Share Price Returns

Is Dong-A ST Co., Ltd.'s (KRX:170900) Stock's Recent Performance A Reflection Of Its Financial Health?

Dong-A ST Co., Ltd. Completes the Proof-Of-Concept Study for ‘DA-1241,’ an Investigational First-In-Class Small Molecule with Mechanism of GPR119 Agonist Under Clinical Development, in Patients with Type 2 Diabetes

Dong-A ST Co., Ltd. to Report Fiscal Year 2020 Results on Feb 03, 2021

New 90-day low: ₩82,500

Is Dong-A ST Co., Ltd. (KRX:170900) Popular Amongst Institutions?

Is Dong-A ST Co., Ltd. (KRX:170900) A Good Fit For Your Dividend Portfolio?

Be Sure To Check Out Dong-A ST Co., Ltd. (KRX:170900) Before It Goes Ex-Dividend

Dong-A ST (KRX:170900) Has A Rock Solid Balance Sheet

Upcoming Dividend of ₩1,000 Per Share

New 90-day low: ₩83,800

Calculating The Intrinsic Value Of Dong-A ST Co., Ltd. (KRX:170900)

A Look At Dong-A ST's (KRX:170900) Share Price Returns

New 90-day low: ₩85,000

New 90-day high - ₩104,500

Dong-A ST Co., Ltd. to Report First Half, 2020 Results on Jul 29, 2020

CEO

Bestuursleden

Gemiddelde duur